Neil Walker

Direttore/Membro del Consiglio presso Helio Vision, Inc.

Health Technology

Provenienza dei contatti di primo grado di Neil Walker

Entità	Tipo di entità	Settore Industriale
Helio Vision, Inc. Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. 8	Subsidiary	Pharmaceuticals: Major	8

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Neil Walker tramite i suoi contatti personali

Società	Settore	Persone collegate	Posizione principale
Bausch & Lomb, Inc. Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.	Medical Specialties	Gary Phillips	Corporate Officer/Principal
MERCK & CO., INC.	Pharmaceuticals: Major	Nancy Miller-Rich	Corporate Officer/Principal
Schering-Plough Corp. Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.	Pharmaceuticals: Major	Nancy Miller-Rich	Corporate Officer/Principal
NOVAVAX, INC.	Biotechnology	Richard Douglas	Director/Board Member
ADERIS Pharmaceuticals, Inc. ADERIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ADERIS Pharmaceuticals, Inc. develops and commercializes drugs and pharmaceuticals. It engages in small molecule drug development to treat central nervous system, cardiovascular, and inflammatory disorders. The company was founded by Donald McAfee, Noel Cusack, Gevork I. Minaskanian, and Peter Savasand in 1994 and is headquartered in Hopkinton, MA.	Pharmaceuticals: Major	Todd Brady	Chief Tech/Sci/R&D Officer
MAXCYTE, INC.	Biotechnology	Richard Douglas	Chairman
Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	Pharmaceuticals: Generic	Nancy Miller-Rich	Director/Board Member
ALDEYRA THERAPEUTICS, INC.	Biotechnology	Gary Phillips Martin Joyce Jesse I. Treu Ben Bronstein Todd Brady Richard Douglas Nancy Miller-Rich	Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Chairman Director/Board Member
INTERCEPT PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Nancy Miller-Rich	Director/Board Member
EVOKE PHARMA, INC.	Pharmaceuticals: Major	Todd Brady	Director/Board Member
eXIthera Pharmaceuticals, Inc. eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA.	Biotechnology	Ben Bronstein	Director/Board Member
KADMON HOLDINGS, INC.	Biotechnology	Nancy Miller-Rich	Director/Board Member
ACLARIS THERAPEUTICS, INC.	Pharmaceuticals: Major	Ben Bronstein	Chief Tech/Sci/R&D Officer
Domain Associates LLC Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey.	Investment Managers	Jesse I. Treu Todd Brady	Private Equity Investor Private Equity Investor
Dartmouth College	College/University	Todd Brady	Undergraduate Degree
UDG HEALTHCARE PLC	Miscellaneous Commercial Services	Nancy Miller-Rich	Director/Board Member
Boston University	College/University	Ben Bronstein	Doctorate Degree
BioSurface Technology, Inc. BioSurface Technology, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, BioSurface Technology, Inc. is a commercial biotechnical research company. The company is based in Cambridge, MA. The company was founded by David L. Castaldi, Ben R. Bronstein. BioSurface Technology was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on December 16, 1994.	Miscellaneous Commercial Services	Ben Bronstein	Founder
Echelon Ventures Echelon Ventures Investment ManagersFinance Echelon Ventures (Echelon Ventures) is a venture capital firm founded in 2000 by Woody S Woodworth and Scott C McCabe. The firm is headquartered in Waltham, Massachusetts.	Investment Managers	Ben Bronstein	Private Equity Investor
Ithaca College	College/University	Nancy Miller-Rich	Undergraduate Degree
University of California, Berkeley	College/University	Richard Douglas	Doctorate Degree
University of Michigan	College/University	Richard Douglas	Undergraduate Degree
IOMAI CORPORATION	Biotechnology	Jesse I. Treu Richard Douglas	Director/Board Member Director/Board Member
Penn Medicine Princeton Health Penn Medicine Princeton Health Hospital/Nursing ManagementHealth Services Penn Medicine Princeton Health provides health care services. It serves the lifelong needs of central New Jersey residents, including acute care hospital services through University Medical Center of Princeton, behavioral healthcare through Princeton House Behavioral Health, rehabilitation, home care, hospice care, ambulatory surgery, a medical practice, and fitness and wellness services. The company was founded in 1978 and is headquartered in Plainsboro, NJ.	Hospital/Nursing Management	Jesse I. Treu	Director/Board Member
CardioPolymers, Inc. CardioPolymers, Inc. Pharmaceuticals: MajorHealth Technology CardioPolymers, Inc. provides novel biocompatible polymer implant therapies to treat cronic heart failures. The company was founded in 2003 and is headquartered in Laguna Hills, CA.	Pharmaceuticals: Major	Todd Brady	Director/Board Member
OPKO HEALTH, INC.	Medical/Nursing Services	Ben Bronstein	Founder
Integrated Genetics, Inc. Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The company is based in Framingham, MA. The company was founded by Robert J. Carpenter.	Pharmaceuticals: Major	Richard Douglas	Corporate Officer/Principal
Vidus Ocular, Inc. Vidus Ocular, Inc. Medical SpecialtiesHealth Technology Part of OPKO Health, Inc., Vidus Ocular, Inc. is a company that manufactures shunts to treat glaucoma. The company is based in New Haven, CT. Vidus Ocular was acquired by OPKO Health, Inc. on May 07, 2008 for $2.71 million. The company was founded by James R. McNab, Ben R. Bronstein.	Medical Specialties	Ben Bronstein	Founder
NovaDigm Therapeutics, Inc. NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND.	Pharmaceuticals: Major	Todd Brady	Director/Board Member
Technicon Instruments Corp.		Jesse I. Treu	Corporate Officer/Principal
Phenome Sciences, Inc.		Todd Brady	Chief Executive Officer
OUTLOOK THERAPEUTICS, INC.	Pharmaceuticals: Major	Todd Brady	Director/Board Member
Duke University School of Medicine	College/University	Todd Brady	Doctorate Degree
4D MOLECULAR THERAPEUTICS, INC.	Biotechnology	Nancy Miller-Rich	Director/Board Member
Cleveland Diagnostics, Inc. Cleveland Diagnostics, Inc. Investment Trusts/Mutual FundsMiscellaneous Cleveland Diagnostics, Inc. develops and commercializes cancer diagnostics and screening tests. Its portfolio of non-invasive cancer diagnostic tests includes blood-based tests to screen for prostate, breast, and ovarian cancer. The company was founded by Arnon Chait and Boris Zaslavsky in October 2013 and is headquartered in Cleveland, OH.	Investment Trusts/Mutual Funds	Ben Bronstein	Chairman
Cold Spring Venture Advisors LLC Cold Spring Venture Advisors LLC Investment ManagersFinance Cold Spring Venture Advisors LLC provides investment management services. The private company is based in Newton, MA.	Investment Managers	Ben Bronstein	Corporate Officer/Principal
Altum Pharmaceuticals, Inc. Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada.	Pharmaceuticals: Generic	Nancy Miller-Rich	Chairman
STEALTH BIOTHERAPEUTICS CORP	Biotechnology	Ben Bronstein	Chief Tech/Sci/R&D Officer
TEN63 Therapeutics TEN63 Therapeutics Pharmaceuticals: MajorHealth Technology TEN63 Therapeutics provides drug development services. The American company was founded by Nancy Miller-Rich, Marcel Frenkel, Mark Hallen, Bruce Donald. Marcel Frenkel has been the CEO since incorporation.	Pharmaceuticals: Major	Nancy Miller-Rich	Founder
Attralus, Inc. Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA.	Pharmaceuticals: Major	Nancy Miller-Rich	Director/Board Member
Labyrinth Choir, Inc.		Richard Douglas	Director/Board Member
Miller-Rich Associates LLC		Nancy Miller-Rich	Chief Executive Officer
Sentien Biotechnologies, Inc. Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Sentien Biotechnologies, Inc. develops cell-based therapy for critical care. It provides the Sentinel, a device that actively treats patients during a dialysis dose by supplementing patient blood with MSC-derived secretions. The company was founded by Brian Miller and Biju Parekkadan and is headquartered in Lexington, MA.	Biotechnology	Ben Bronstein	Corporate Officer/Principal